Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Patheon Manufacturing Services LLC | Ridgefield, NJ, United States | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyMar 18, 2024 · 8 inspections |
| Sanofi Winthrop Industrie | Le Trait, France | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyApr 25, 2023 · 6 inspections |
| Sanofi-Aventis Singapore Pte. Ltd. | Singapore, Singapore | Makes the active ingredient and tests it | Problems found, fixed voluntarilyJun 13, 2025 · 6 inspections |
Recalls
- Dec 5, 2017 · Class III · Sanofi-Aventis U.S. LLC
Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL
Lots: Lot #: 7S572, Exp. 04/2019
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Enoxaparin: every company that makes it
- Form
- injection, subcutaneous
- Strength
- 120 mg per 0.8 mL
- Approval
- NDA authorized generic NDA020164
- On the market since
- Oct 3, 2011
- Package NDCs
0955-1012-010955-1012-10- Official label
- DailyMed (National Library of Medicine), updated Sep 17, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?